Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous platelet-rich plasma vs corticosteroid injection in lateral epicondylitis
2006-002198-32Phase 4Active
- Sponsor
- Zimmer Biomet
- Start
- May 2006
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of autologous platelet-rich plasma in Lateral Epicondylitis (LET) (2 arms), sponsored by Zimmer Biomet. Primary endpoint: Primary endpoint: pain reduction and duration of condition. Started May 2006; status: active.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on 2006-002198-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002198-32.